Uzma Salar

3.1k total citations
118 papers, 2.6k citations indexed

About

Uzma Salar is a scholar working on Organic Chemistry, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Uzma Salar has authored 118 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Organic Chemistry, 36 papers in Molecular Biology and 25 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Uzma Salar's work include Synthesis and biological activity (66 papers), Synthesis and Characterization of Heterocyclic Compounds (28 papers) and Natural Antidiabetic Agents Studies (23 papers). Uzma Salar is often cited by papers focused on Synthesis and biological activity (66 papers), Synthesis and Characterization of Heterocyclic Compounds (28 papers) and Natural Antidiabetic Agents Studies (23 papers). Uzma Salar collaborates with scholars based in Pakistan, Saudi Arabia and Malaysia. Uzma Salar's co-authors include Khalid Mohammed Khan, Muhammad Taha, Shahnaz Perveen, Abdul Wadood, Nor Hadiani Ismail, Sridevi Chigurupati, Kanwal, Syahrul Imran, Muhammad Riaz and Farman Ali and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Biological Macromolecules.

In The Last Decade

Uzma Salar

112 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Uzma Salar Pakistan	31	2.0k	703	560	358	295	118	2.6k
Syahrul Imran Malaysia	36	2.3k 1.1×	851 1.2×	879 1.6×	482 1.3×	291 1.0×	92	3.1k
Maryam Mohammadi‐Khanaposhtani Iran	30	1.9k 0.9×	718 1.0×	559 1.0×	393 1.1×	491 1.7×	112	2.6k
Muhammad Ashraf Pakistan	26	1.2k 0.6×	518 0.7×	315 0.6×	227 0.6×	514 1.7×	103	2.0k
Khalid Mohammed Khan Pakistan	28	1.3k 0.7×	451 0.6×	426 0.8×	180 0.5×	138 0.5×	75	1.9k
Manikandan Selvaraj Malaysia	25	1.0k 0.5×	406 0.6×	339 0.6×	299 0.8×	229 0.8×	52	1.5k
Aftab Alam Pakistan	25	997 0.5×	474 0.7×	205 0.4×	259 0.7×	177 0.6×	98	1.6k
Kanwal Pakistan	22	810 0.4×	318 0.5×	275 0.5×	184 0.5×	134 0.5×	48	1.2k
Zaman Ashraf Pakistan	26	962 0.5×	542 0.8×	75 0.1×	189 0.5×	195 0.7×	97	2.0k
Atia‐tul Wahab Pakistan	23	555 0.3×	770 1.1×	286 0.5×	180 0.5×	217 0.7×	135	1.7k
Matloob Ahmad Pakistan	26	1.2k 0.6×	566 0.8×	110 0.2×	188 0.5×	166 0.6×	151	1.8k

Countries citing papers authored by Uzma Salar

Since Specialization

Citations

This map shows the geographic impact of Uzma Salar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uzma Salar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uzma Salar more than expected).

Fields of papers citing papers by Uzma Salar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uzma Salar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uzma Salar. The network helps show where Uzma Salar may publish in the future.

Co-authorship network of co-authors of Uzma Salar

This figure shows the co-authorship network connecting the top 25 collaborators of Uzma Salar. A scholar is included among the top collaborators of Uzma Salar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uzma Salar. Uzma Salar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ghoran, Salar Hafez & Uzma Salar. (2025). Saturation transfer difference (STD)-NMR spectroscopy in drug discovery: A comprehensive review on identified potential hits based on natural and synthetic scaffolds against therapeutic drug targets. Bioorganic & Medicinal Chemistry. 125. 118212–118212. 1 indexed citations

Ahmad, Asif, Uzma Salar, Musa Özil, et al.. (2025). Piperonal-derived (E)-2-(2-(Benzo[d][1,3]dioxol-5-ylmethylene)hydrazineyl)-4-(aryl)thiazole derivatives as potential therapeutic leads for diabetes and Alzheimer's disease: In vitro and in silico evaluation against α-glucosidase, α-amylase, acetylcholinesterase, and butyrylcholinesterase. Journal of Molecular Structure. 1338. 142306–142306.

Ali, Muhammad, Khalid Mohammed Khan, Parham Taslımı, et al.. (2025). Design, synthesis, and biological evaluation of 3-phenylimidazo[1,2-a]pyridine derivatives as diverse enzyme inhibitors. Journal of the Iranian Chemical Society. 22(4). 797–817.

Ali, Muhammad, Shahbaz Shamim, Uzma Salar, et al.. (2024). 2-amino-6-ethoxy-4-arylpyridine-3,5-dicarbonitrile Scaffolds as potential acetylcholinesterase and butyrylcholinesterase inhibitors. Journal of Molecular Structure. 1321. 139863–139863. 8 indexed citations

Ambreen, Nida, Faiza Saleem, Muhammad Arif Lodhi, et al.. (2024). Nicotinonitriles as potential inhibitors of α-glucosidase, tyrosinase, and urease enzymes: Synthesis, characterization, in vitro, and in silico studies. Journal of Molecular Structure. 1305. 137742–137742. 4 indexed citations

Khan, Khalid Mohammed, Sridevi Chigurupati, Uzma Salar, et al.. (2024). Rhodanine-benzamides as potential hits for α-amylase enzyme inhibitors and radical (DPPH and ABTS) scavengers. Molecular Diversity. 29(5). 3857–3875.

Saleem, Faiza, Khalid Mohammed Khan, Musa Özil, et al.. (2023). Regioselective syntheses of 2-oxopyridine carbonitrile derivatives and evaluation for antihyperglycemic and antioxidant potential. International Journal of Biological Macromolecules. 241. 124589–124589. 13 indexed citations

Salar, Uzma, Sridevi Chigurupati, Suliman A. Almahmoud, et al.. (2023). Synthetic piperidine-substituted Chalcones As Potential Hits for α-amylase Inhibitory and Antioxidant Activities. Future Medicinal Chemistry. 15(6). 497–515. 4 indexed citations

Khan, Momin, Aftab Alam, Ajmal Khan, et al.. (2023). Synthesis of new bis(dimethylamino)benzophenone hydrazone for diabetic management: In-vitro and in-silico approach. Heliyon. 10(1). e23323–e23323. 31 indexed citations

10.

Hameed, Shehryar, Khalid Mohammed Khan, Uzma Salar, et al.. (2022). Hydrazinyl thiazole linked indenoquinoxaline hybrids: Potential leads to treat hyperglycemia and oxidative stress; Multistep synthesis, α-amylase, α-glucosidase inhibitory and antioxidant activities. International Journal of Biological Macromolecules. 221. 1294–1312. 28 indexed citations

11.

Hameed, Shehryar, Khalid Mohammed Khan, Parham Taslımı, et al.. (2022). Evaluation of synthetic 2-aryl quinoxaline derivatives as α-amylase, α-glucosidase, acetylcholinesterase, and butyrylcholinesterase inhibitors. International Journal of Biological Macromolecules. 211. 653–668. 34 indexed citations

12.

Shamim, Shahbaz, Khalid Mohammed Khan, Nisar Ullah, et al.. (2020). Synthesis and screening of (E)-3-(2-benzylidenehydrazinyl)-5,6-diphenyl-1,2,4-triazine analogs as novel dual inhibitors of α-amylase and α-glucosidase. Bioorganic Chemistry. 101. 103979–103979. 38 indexed citations

13.

Salar, Uzma, Khalid Mohammed Khan, Almas Jabeen, et al.. (2019). ROS Inhibitory Activity and Cytotoxicity Evaluation of Benzoyl, Acetyl, Alkyl Ester, and Sulfonate Ester Substituted Coumarin Derivatives. Medicinal Chemistry. 16(8). 1099–1111. 5 indexed citations

14.

Kanwal, Khalid Mohammed Khan, Farida Begum, et al.. (2018). Benzylidine indane-1,3-diones: As novel urease inhibitors; synthesis, in vitro, and in silico studies. Bioorganic Chemistry. 81. 658–671. 13 indexed citations

15.

Khan, Khalid Mohammed, Uzma Salar, Sridevi Chigurupati, et al.. (2018). Chalcones and bis-chalcones: As potential α-amylase inhibitors; synthesis, in vitro screening, and molecular modelling studies. Bioorganic Chemistry. 79. 179–189. 48 indexed citations

16.

Mohiuddin, Ghulam, Khalid Mohammed Khan, Uzma Salar, et al.. (2018). Biology-oriented drug synthesis (BIODS), in vitro urease inhibitory activity, and in silico study of S-naproxen derivatives. Bioorganic Chemistry. 83. 29–46. 26 indexed citations

17.

Zafar, Humaira, Muhammad Abid Hayat, Sumayya Saied, et al.. (2017). Xanthine oxidase inhibitory activity of nicotino/isonicotinohydrazides: A systematic approach from in vitro, in silico to in vivo studies. Bioorganic & Medicinal Chemistry. 25(8). 2351–2371. 32 indexed citations

18.

Salar, Uzma, Khalid Mohammed Khan, Muhammad Taha, et al.. (2017). Synthesis, in vitro β -glucuronidase inhibitory activity and in silico studies of novel ( E )-4-Aryl-2-(2-(pyren-1-ylmethylene)hydrazinyl)thiazoles. Bioorganic Chemistry. 70. 199–209. 10 indexed citations

19.

Stieglitz, Kimberly A., Shamsher Ali, Asma Ejaz, et al.. (2016). Coumarin and Biscoumarin Inhibit <i>in Vitro</i> Obesity Model. Advances in Biological Chemistry. 6(5). 152–168. 10 indexed citations

20.

Taha, Muhammad, Nor Hadiani Ismail, Syahrul Imran, et al.. (2016). Synthesis of 6-chloro-2-Aryl-1H-imidazo[4,5-b]pyridine derivatives: Antidiabetic, antioxidant, β-glucuronidase inhibiton and their molecular docking studies. Bioorganic Chemistry. 65. 48–56. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact